Mostafa Salimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mostafa Salimi has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Farzaneh Mohammadi
Faculty of Medicine Students Research Committee MMS.C Islamic Azad University of Mashhad Mashhad Iran
2 shared publications- Azin Alizadehasl
Cardio‐Oncology Research Center Rajaie Cardiovascular Medical and Research Institute Tehran Iran
1 shared publication - Farnood Forouhar
Department of General Surgery, Faculty of Medicine, Mashhad Medical Sciences Islamic Azad University Mashhad Iran
1 shared publication Ghazal Yazdani
1 shared publication- Helia Taherian
Student Research Committee, Faculty of Medicine, MMS.C., Islamic Azad University, Mashhad, Iran
1 shared publication - Hoda Mohammadkhani
Department of Obstetrics and Gynecology, MMS.C., Islamic Azad University, Mashhad, Iran
1 shared publication
Latest Publications
- Open Access
- 24 August 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
Spontaneous oblique posterior lower segment-to-cornual uterine rupture in an unscarred primigravida at term: a case report
- 24 August 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
Open AccessSpontaneous oblique posterior lower segment-to-cornual uterine rupture in an unscarred primigravida at term: a case report
- Open Access
- 6 July 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (7) , e72267
Rare Late Cardiac Involvement Following Resected Primary Limb Dedifferentiated Liposarcoma: A Case Report
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive subtype of soft tissue sarcoma, most commonly arising in the extremities or retroperitoneum. Cardiac involvement, whether primary or metastatic, is exceedingly rare and presents significant diagnostic and therapeutic challenges. We present the case of a 68‐year‐old woman with a history of lower limb DDLPS who experienced progressive dyspnea and was subsequently found to have a large mediastinal mass with pericardial involvement. Cardiovascular magnetic resonance (CMR) revealed imaging features consistent with a malignant lesion, including heterogeneous enhancement and tissue characteristics indicative of sarcoma. Given the patient's oncological history and the imaging findings, a diagnosis of metastatic cardiac DDLPS was favored. Surgical resection was deemed infeasible due to extensive pericardial involvement, and the patient underwent multiple lines of chemotherapy. Although there was initial disease control, she ultimately succumbed to septic shock resulting from a urinary tract infection. This case emphasizes the importance of considering metastatic sarcoma in the differential diagnosis of cardiac masses, particularly in patients with a known history of soft tissue malignancy. It also highlights the diagnostic value of CMR and the necessity for multidisciplinary management in complex, nonresectable cases.
- 6 July 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (7) , e72267
Open AccessRare Late Cardiac Involvement Following Resected Primary Limb Dedifferentiated Liposarcoma: A Case Report
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive subtype of soft tissue sarcoma, most commonly arising in the extremities or retroperitoneum. Cardiac involvement, whether primary or metastatic, is exceedingly rare and presents significant diagnostic and therapeutic challenges. We present the case of a 68‐year‐old woman with a history of lower limb DDLPS who experienced progressive dyspnea and was subsequently found to have a large mediastinal mass with pericardial involvement. Cardiovascular magnetic resonance (CMR) revealed imaging features consistent with a malignant lesion, including heterogeneous enhancement and tissue characteristics indicative of sarcoma. Given the patient's oncological history and the imaging findings, a diagnosis of metastatic cardiac DDLPS was favored. Surgical resection was deemed infeasible due to extensive pericardial involvement, and the patient underwent multiple lines of chemotherapy. Although there was initial disease control, she ultimately succumbed to septic shock resulting from a urinary tract infection. This case emphasizes the importance of considering metastatic sarcoma in the differential diagnosis of cardiac masses, particularly in patients with a known history of soft tissue malignancy. It also highlights the diagnostic value of CMR and the necessity for multidisciplinary management in complex, nonresectable cases.
- Open Access
- 2 July 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1)
The role of antileukotriene therapy in COPD management: a systematic review and meta-analysis of randomized controlled trials
Background: Chronic Obstructive Pulmonary Disease (COPD) is a prevalent lung condition that impairs breathing and daily activities, manifesting symptoms such as a persistent cough, shortness of breath, and chest tightness. Antileukotrienes, including Montelukast, Zafirlukast, and Zileuton, are used to manage inflammation in asthma; however, according to the 2025 GOLD reports, their efficacy in treating COPD remains unclear. This systematic review and meta-analysis aim to evaluate the role of antileukotriene therapy in patients with COPD. Method: This systematic review was reported in accordance with the PRISMA guidelines. In July 2023, a comprehensive search was conducted across Scopus, Web of Science, PubMed, Cochrane Library, and Embase. The review included only randomized controlled trials that compared anti-leukotriene agents with a placebo. A meta-analysis was performed on Forced Expiratory Volume in 1 s(FEV1), Leukotriene B4(LTB4), and Myeloperoxidase(MPO), utilizing standardized mean differences(SMD) with a 95% confidence interval(CI). C-reactive protein(CRP), quality of life and adverse events data were summarized narratively. Results: This meta-analysis encompassed nine randomized controlled trials involving a total of 506 participants. The findings indicated that anti-leukotriene therapy led to a significant overall improvement in FEV1 (SMD = 0.63, 95%CI 0.15 to 1.11, p = 0.01), although high heterogeneity was noted(I 2 = 83%). A subgroup analysis focusing specifically on leukotriene receptor antagonists revealed a more consistent and potent effect on FEV1 (SMD = 1.00, 95%CI 0.75 to 1.25, p < 0.001) with low heterogeneity. Notably, both Montelukast(SMD = 1.15) and Zafirlukast(SMD = 0.75) displayed significant benefits. In contrast, no significant improvements were found in the inflammatory markers LTB4 (SMD=-0.42) or MPO (SMD=-0.14). CRP results were inconclusive, while quality of life scores showed improvement in the montelukast groups. Adverse events were comparable between groups or reduced in the experimental group. Conclusion: Analysis indicates that anti-leukotriene therapy, particularly with Montelukast and Zafirlukast, may lead to a modest improvement in lung function and quality of life. Subgroup analyses suggest a potential benefit specifically for Montelukast, although this requires further confirmation. In contrast, Zileuton, which operates via a different mechanism, did not demonstrate any beneficial effects. Given the limitations in sample size and heterogeneity, these findings should be considered exploratory, and additional research is essential to validate these results in larger studies.
- 2 July 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1)
Open AccessThe role of antileukotriene therapy in COPD management: a systematic review and meta-analysis of randomized controlled trials
Background: Chronic Obstructive Pulmonary Disease (COPD) is a prevalent lung condition that impairs breathing and daily activities, manifesting symptoms such as a persistent cough, shortness of breath, and chest tightness. Antileukotrienes, including Montelukast, Zafirlukast, and Zileuton, are used to manage inflammation in asthma; however, according to the 2025 GOLD reports, their efficacy in treating COPD remains unclear. This systematic review and meta-analysis aim to evaluate the role of antileukotriene therapy in patients with COPD. Method: This systematic review was reported in accordance with the PRISMA guidelines. In July 2023, a comprehensive search was conducted across Scopus, Web of Science, PubMed, Cochrane Library, and Embase. The review included only randomized controlled trials that compared anti-leukotriene agents with a placebo. A meta-analysis was performed on Forced Expiratory Volume in 1 s(FEV1), Leukotriene B4(LTB4), and Myeloperoxidase(MPO), utilizing standardized mean differences(SMD) with a 95% confidence interval(CI). C-reactive protein(CRP), quality of life and adverse events data were summarized narratively. Results: This meta-analysis encompassed nine randomized controlled trials involving a total of 506 participants. The findings indicated that anti-leukotriene therapy led to a significant overall improvement in FEV1 (SMD = 0.63, 95%CI 0.15 to 1.11, p = 0.01), although high heterogeneity was noted(I 2 = 83%). A subgroup analysis focusing specifically on leukotriene receptor antagonists revealed a more consistent and potent effect on FEV1 (SMD = 1.00, 95%CI 0.75 to 1.25, p < 0.001) with low heterogeneity. Notably, both Montelukast(SMD = 1.15) and Zafirlukast(SMD = 0.75) displayed significant benefits. In contrast, no significant improvements were found in the inflammatory markers LTB4 (SMD=-0.42) or MPO (SMD=-0.14). CRP results were inconclusive, while quality of life scores showed improvement in the montelukast groups. Adverse events were comparable between groups or reduced in the experimental group. Conclusion: Analysis indicates that anti-leukotriene therapy, particularly with Montelukast and Zafirlukast, may lead to a modest improvement in lung function and quality of life. Subgroup analyses suggest a potential benefit specifically for Montelukast, although this requires further confirmation. In contrast, Zileuton, which operates via a different mechanism, did not demonstrate any beneficial effects. Given the limitations in sample size and heterogeneity, these findings should be considered exploratory, and additional research is essential to validate these results in larger studies.
- Open Access
- 27 January 2026
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 23 (11) , 953-960
Fimbria torsion as a rare cause of lower abdominal pain: A case report and literature review
Background: Isolated fimbrial torsion is a rare gynecological emergency that can lead to severe complications if not promptly diagnosed. Its clinical presentation often mimics more common causes of abdominal pain, creating a significant diagnostic challenge. Case Presentation: This case report describes a 47-yr-old woman presenting with right lower quadrant abdominal pain. The initial clinical and ultrasound findings were suggestive of acute appendicitis. However, diagnostic laparoscopy revealed isolated gangrenous torsion of the right fallopian tube fimbria. Conclusion: This case underscores the importance of including fimbrial torsion in the differential diagnosis of right lower quadrant pain in women, even when clinical signs suggest a more common etiology. A comprehensive intraoperative evaluation is crucial when initial findings do not fully explain the clinical presentation, ensuring timely intervention and prevention of long-term complications.
- 27 January 2026
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 23 (11) , 953-960
Open AccessFimbria torsion as a rare cause of lower abdominal pain: A case report and literature review
Background: Isolated fimbrial torsion is a rare gynecological emergency that can lead to severe complications if not promptly diagnosed. Its clinical presentation often mimics more common causes of abdominal pain, creating a significant diagnostic challenge. Case Presentation: This case report describes a 47-yr-old woman presenting with right lower quadrant abdominal pain. The initial clinical and ultrasound findings were suggestive of acute appendicitis. However, diagnostic laparoscopy revealed isolated gangrenous torsion of the right fallopian tube fimbria. Conclusion: This case underscores the importance of including fimbrial torsion in the differential diagnosis of right lower quadrant pain in women, even when clinical signs suggest a more common etiology. A comprehensive intraoperative evaluation is crucial when initial findings do not fully explain the clinical presentation, ensuring timely intervention and prevention of long-term complications.
- Open Access
- 27 December 2025
- Published by European Publishing in Pneumon
- Vol. 38 (4) , 1-9
Applying virtual reality for rehabilitation in COPD patients: A systematic review and meta-analysis of randomized controlled trials
- 27 December 2025
- Published by European Publishing in Pneumon
- Vol. 38 (4) , 1-9
Open AccessApplying virtual reality for rehabilitation in COPD patients: A systematic review and meta-analysis of randomized controlled trials
- Open Access
- 26 September 2025
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 30 (1) , 1-10
Efficacy of naltrexone and bupropion combination in patients with binge eating disorder: a systematic review and meta-analysis
Purpose Binge Eating Disorder (BED) is a prevalent condition with limited evidence-based treatments. Naltrexone and Bupropion Combination (NB) targets neurobiological pathways implicated in BED. The Objective of this paper is to evaluate the efficacy of NB for BED in adults through a systematic review and meta-analysis. Methods Following PRISMA guidelines, we searched major databases and trial registries (up to Feb 2025) for randomized controlled trials (RCTs) comparing NB to placebo or usual care in adults with BED. The primary outcome was binge eating frequency; secondary outcomes included weight loss and BMI. Risk of bias (ROB2) and certainty of evidence (GRADE) were assessed. A fixed-effects meta-analysis was performed. Results Four RCTs (n = 444 participants) met inclusion criteria. Meta-analysis of three studies indicated NB did not significantly reduce binge eating frequency compared to controls (Mean Difference [MD] − 1.49, 95% CI − 3.63 to 0.64, p = 0.17). However, NB significantly reduced weight (MD -3.57 kg, 95% CI − 4.86 to − 2.27, p < 0.001) and BMI (MD − 1.24 kg/m2, 95% CI − 1.79 to − 0.70, p < 0.001). The certainty of evidence was assessed as moderate for binge frequency and low for weight and BMI outcomes. Conclusion NB aids weight reduction in adults with BED, but current evidence is insufficient to confirm its efficacy for reducing binge eating frequency. Further high-quality RCTs are warranted. Level of evidence Level I, systematic reviews and meta-analyses.
- 26 September 2025
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 30 (1) , 1-10
Open AccessEfficacy of naltrexone and bupropion combination in patients with binge eating disorder: a systematic review and meta-analysis
Purpose Binge Eating Disorder (BED) is a prevalent condition with limited evidence-based treatments. Naltrexone and Bupropion Combination (NB) targets neurobiological pathways implicated in BED. The Objective of this paper is to evaluate the efficacy of NB for BED in adults through a systematic review and meta-analysis. Methods Following PRISMA guidelines, we searched major databases and trial registries (up to Feb 2025) for randomized controlled trials (RCTs) comparing NB to placebo or usual care in adults with BED. The primary outcome was binge eating frequency; secondary outcomes included weight loss and BMI. Risk of bias (ROB2) and certainty of evidence (GRADE) were assessed. A fixed-effects meta-analysis was performed. Results Four RCTs (n = 444 participants) met inclusion criteria. Meta-analysis of three studies indicated NB did not significantly reduce binge eating frequency compared to controls (Mean Difference [MD] − 1.49, 95% CI − 3.63 to 0.64, p = 0.17). However, NB significantly reduced weight (MD -3.57 kg, 95% CI − 4.86 to − 2.27, p < 0.001) and BMI (MD − 1.24 kg/m2, 95% CI − 1.79 to − 0.70, p < 0.001). The certainty of evidence was assessed as moderate for binge frequency and low for weight and BMI outcomes. Conclusion NB aids weight reduction in adults with BED, but current evidence is insufficient to confirm its efficacy for reducing binge eating frequency. Further high-quality RCTs are warranted. Level of evidence Level I, systematic reviews and meta-analyses.
- Open Access
- 23 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70226
Endometriosis Presenting as a Rare Cause of Intestinal Perforation: A Case Report With Literature Review
This case report details a 39‐year‐old woman with a history of endometriosis who presented with severe abdominal pain, vomiting, and nausea, leading to a diagnosis of intestinal perforation caused by endometriosis. The patient underwent emergency surgery to resect the perforated bowel and an adjacent mass. Pathology confirmed the presence of endometrial tissue within the intestinal wall. This case underscores the importance of considering endometriosis in the differential diagnosis of acute abdominal pain, particularly in women with a history of the disease. Early diagnosis and prompt surgical intervention are crucial for managing this potentially life‐threatening complication.
- 23 February 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70226
Open AccessEndometriosis Presenting as a Rare Cause of Intestinal Perforation: A Case Report With Literature Review
This case report details a 39‐year‐old woman with a history of endometriosis who presented with severe abdominal pain, vomiting, and nausea, leading to a diagnosis of intestinal perforation caused by endometriosis. The patient underwent emergency surgery to resect the perforated bowel and an adjacent mass. Pathology confirmed the presence of endometrial tissue within the intestinal wall. This case underscores the importance of considering endometriosis in the differential diagnosis of acute abdominal pain, particularly in women with a history of the disease. Early diagnosis and prompt surgical intervention are crucial for managing this potentially life‐threatening complication.
- Open Access
- 20 December 2023
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 92 (1) , 13-14
Comment on Patsaki et al. Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis. Adv. Respir. Med. 2023, 91, 324–336
I am writing this comment regarding the review article by Patsaki et al. titled “Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis”
- 20 December 2023
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 92 (1) , 13-14
Open AccessComment on Patsaki et al. Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis. Adv. Respir. Med. 2023, 91, 324–336
I am writing this comment regarding the review article by Patsaki et al. titled “Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis”